Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the ...

One in eight adults in the U.S. has taken Ozempic or another type of GLP-1 drug, surveys show — and now a major new study has revealed a long list of benefits and some little-known risks.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of American adults meeting the criteria for being obese or ...

Ozempic (semaglutide) is a GLP-1 RA (glucagon-like peptide-1 receptor agonist), also known as a “GLP-1” drug. It’s an effective medication for managing type 2 diabetes and for weight loss.

What to Eat on Ozempic and What to Avoid Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this GLP-1 (glucagon-like peptide 1 ...

From heart and kidney health to addiction reduction, GLP-1 drugs like Ozempic and Mounjaro may help with more than just weight loss Steve Christo/Corbis/Corbis/Getty ...

Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change the way America eats, food manufacturers are trying to whip themselves up a forkful of the action ...

Dr. Omer Awan is a practicing physician who covers public health. Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to its ...

There's an emerging market of "natural" supplements that claim to cause weight loss like Ozempic and similar drugs. Hunterframe - stock.adobe.com UK scientists said they have developed a low-cost ...

Mounjaro vs. Ozempic: Which Is Better for Weight Loss? This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re ...

The move could mean savings for consumers. Weight loss drugs Ozempic and Wegovy have been added to the list of medications Medicare will be able to negotiate directly with drug manufacturers ...

If the risk remains consistent over time, a type 2 diabetes patient taking Ozempic for 20 years would face a 0.3% to 0.5% likelihood of developing NAION, according to the study. The findings for ...